HIMS vs TECH · P/E 74, rev $1.48B vs P/E 65, rev $1.22B
Hims Hers Health Inc (HIMS) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Hims Hers Health Inc (HIMS) is a household & personal products company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported HIMS revenue for 2024-12-31 was $1.48B. Net income was $126.0M. Revenue was up 69.3% from 2023-12-31 to 2024-12-31. HIMS currently screens at market cap $11.04B and trailing P/E 73.9.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
HIMS currently screens at market cap $11.04B and trailing P/E 73.9. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the HIMS and TECH stock pages for the full models.
Not investment advice.